A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

"Symptoms of ovarian cancer are vague, non-specific, and occur with a variety of conditions," Dr. Priyal Dholakiya, MD, a ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Most women with epithelial ovarian cancer are diagnosed with stage III ... repeated paracentesis for ascites, and/or multiple thoracentesis for pleural effusions 1A Growth limited to one ovary ...

Prognostic impact of postoperative complications after neoadjuvant therapy followed by esophagectomy for esophageal cancer: An exploratory analysis of phase III trial JCOG1109.

About 107,320 new cases of colon cancer (54,510 in men and 52,810 in women) About 46,950 new cases of rectal cancer (27,950 in men and 19,000 in women) The rate of people being diagnosed with colon or ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

Background: Ovarian cancer is among the most lethal gynecologic malignancies ... with irregular enhancement of the peritoneum, omental nodularity, and ascites suggestive of peritoneal carcinomatosis.